To directly evaluate the effects of IFN-I in lupus nephritis, animals can be induced with recombinant IFN-α, infected with an adenovirus expressing IFN-α or treated with an augmenting IFN-I-amplified antibody (32, 66–68). This evidence concerns the gene IFNA2 and lupus nephritis.